Renal Cancer - Results from #5540

Treatment Outcome of Low-dose Interleukin-2 Therapy in Patients with Metastatic Renal Cell Carcinoma September 22, 2016

Whole-Body MRI Screening in Asymptomatic Subjects; Preliminary Experience and Long-Term Follow-Up Findings September 21, 2016

Pazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale" September 21, 2016

Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma September 20, 2016

Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma September 20, 2016

Cytomorphology of clear cell papillary renal cell carcinoma September 19, 2016

Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma September 16, 2016

Comparing Zero Ischemia Laparoscopic Radio Frequency Ablation Assisted Tumor Enucleation and Laparoscopic Partial Nephrectomy for Clinical T1a Renal Tumor: A Randomized Clinical Trial September 16, 2016

Outcome of surgery for patients with renal cell carcinoma and tumour thrombus in the era of modern targeted therapy September 16, 2016

Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney September 16, 2016

Phase I dose-escalation study of plitidepsin in combination with bevacizumab in patients with refractory solid tumors September 15, 2016

Solitary parotid metastasis 8 years after a nephrectomy for renal cell carcinoma September 15, 2016

Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature September 14, 2016

Acetazolamide serves as selective delivery vehicle for dipeptide-linked drugs to renal cell carcinoma September 14, 2016

Perirenal Fat Promotes Renal Arterial Endothelial Dysfunction in Obese Swine through Tumor Necrosis Factor-a September 13, 2016

Prognostic Significance of Blood Type A in Patients with Renal Cell Carcinoma September 12, 2016

Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer September 12, 2016

The Silencing of CCND2 by Promoter Aberrant Methylation in Renal Cell Cancer and Analysis of the Correlation between CCND2 Methylation Status and Clinical Features September 10, 2016

Medical Expulsive Therapy is Underused for the Management of Renal Colic in the Emergency Setting September 9, 2016

Physapubescin selectively induces apoptosis in VHL-null renal cell carcinoma cells through down-regulation of HIF-2α and inhibits tumor growth. September 8, 2016

Page 278 of 456